Clinical Trial Update: Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating colecalciferol as an add-on to interferon-beta-1b for multiple sclerosis; the study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon beta-1b (Interferon beta-1b)
• colecalciferol (vitamin D3)

Snippet

Sponsor: University of Turku | Conditions: Multiple Sclerosis | Phase 4 | Status: UNKNOWN